Rakesh R Ramjiawan

Rakesh R Ramjiawan

UNVERIFIED PROFILE

Are you Rakesh R Ramjiawan?   Register this Author

Register author
Rakesh R Ramjiawan

Rakesh R Ramjiawan

Publications by authors named "Rakesh R Ramjiawan"

Are you Rakesh R Ramjiawan?   Register this Author

6Publications

333Reads

11Profile Views

Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Angiogenesis 2017 May 30;20(2):185-204. Epub 2017 Mar 30.

E. L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom St, Cox-734, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10456-017-9552-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439974PMC
May 2017

An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.

Nat Protoc 2015 Aug 23;10(8):1264-74. Epub 2015 Jul 23.

Department of Radiation Oncology, Steele Laboratories for Tumor Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nprot.2015.080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800979PMC
August 2015

CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.

Hepatology 2015 May 20;61(5):1591-602. Epub 2015 Mar 20.

E.L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406806PMC
May 2015